Clinical Trials on Free Mucogingival Grafts in New Zealand
Total 257 results
-
Rowan UniversitySuspendedMuscle Strength | Neuromuscular Function | Fat-free MasssUnited States
-
Health DecisionsEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedFocus: Estrogen-free Oral ContraceptionUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); University of Southern California; University...Completed
-
NYU Langone HealthCompleted
-
Icahn School of Medicine at Mount SinaiCompletedHead and Neck Cancer | Free Tissue TransferUnited States
-
Laser LabCorpSuspendedBreast Cancer | Oncology | Cancer Diagnosis | Margins of Excision | Margins, Tumor-FreeUnited States
-
Icahn School of Medicine at Mount SinaiRecruitingHead and Neck Cancer | Free Tissue TransferUnited States
-
Columbia UniversityIncyte CorporationTerminatedGraft Vs Host Disease | Steroid Refractory GVHDUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedGraft Versus Host DiseaseUnited States
-
University of RochesterWithdrawnActive Chronic Graft Versus Host DiseaseUnited States
-
NYU Langone HealthRecruiting
-
NYU Langone HealthActive, not recruitingGraft-versus-host DiseaseUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedGraft Versus Host DiseaseUnited States
-
Lassen Therapeutics 1 PTY LTDRecruitingThyroid Eye Disease | Pulmonary FibrosisAustralia, New Zealand, Hong Kong
-
M.D. Anderson Cancer CenterCompleted
-
University of RochesterTerminatedChronic Graft Versus Host DiseaseUnited States
-
Yale UniversityTerminatedGraft Versus Host DiseaseUnited States
-
The University of QueenslandBaxter Healthcare Corporation; Health Research Council, New Zealand; Australian...CompletedEnd Stage Kidney Disease | Kidney Transplant; Complications | Delayed Graft FunctionAustralia, New Zealand
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedGraft Versus Host Disease | Hematopoietic Cell Transplantation RecipientUnited States
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States, Spain, Belgium, France, Italy, Korea, Republic of, Finland, United Kingdom, Germany, Israel, Switzerland, Austria, Australia, Czechia, Greece, New Zealand, Poland, Portugal, Taiwan
-
NYU Langone HealthRecruitingGraft Vs Host DiseaseUnited States
-
Columbia UniversityCompletedImplant or Graft; RejectionUnited States
-
SoligenixTerminatedChronic Gastrointestinal Graft vs Host DiseaseUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States, Canada, Australia, Switzerland, Puerto Rico, New Zealand
-
Northwell HealthWithdrawnAcute GVH DiseaseUnited States
-
Mesoblast, Inc.No longer availableGraft-Versus-Host DiseaseUnited States
-
NYU Langone HealthCompleted
-
EquilliumBiocon LimitedRecruitingGraft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHDUnited States, Korea, Republic of, Germany, Israel, Spain, Belgium, Italy, Australia, France, Canada, Portugal, New Zealand
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Roswell Park Cancer InstituteCompletedGraft Versus Host DiseaseUnited States
-
Alexion PharmaceuticalsTerminatedAcute Graft-Versus-Host Disease | GIGVHDUnited States, France
-
Hackensack Meridian HealthTerminatedGraft Versus Host DiseaseUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedGraft Rejection | Kidney FailureUnited States, Spain, Canada, Switzerland, Austria, Australia, New Zealand
-
Regimmune CorporationCompletedGraft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Prevention of aGVHDUnited States
-
Genentech, Inc.TerminatedAcute Graft-versus-host DiseaseUnited States, Canada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedGraft Versus Host DiseaseUnited States
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Graft Versus Host DiseaseUnited States
-
NovartisCompletedKidney Transplantation | Graft RejectionUnited States
-
Fresenius Medical Care North AmericaCompletedChronic Kidney Diseases | Patient Requiring Heparin Free Dialysis TreatmentsUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Seagen Inc.Completed
-
Memorial Sloan Kettering Cancer CenterCompletedCD34 Selected Peripheral Blood Stem Cell GraftUnited States
-
Cynata Therapeutics LimitedCompletedGraft vs Host DiseaseAustralia, United Kingdom
-
EVIVE BiotechnologyMemorial Sloan Kettering Cancer CenterCompletedAcute Graft vs Host DiseaseUnited States
-
Genentech, Inc.Completed
-
MallinckrodtParexelCompletedChronic Graft Versus Host DiseaseUnited States, France, Germany, United Kingdom, Spain, Italy, Austria, Hungary
-
Incyte CorporationCompletedGraft-versus-host Disease (GVHD)United States
-
Northwell HealthRecruitingSkin Graft ScarUnited States
-
PlexisionMedical University of South CarolinaUnknownAntibody-Mediated Graft RejectionUnited States
-
Memorial Sloan Kettering Cancer CenterIncyte Corporation; Hackensack Meridian HealthCompletedNon-sclerotic Cutaneous Chronic Graft-versus-host DiseaseUnited States